News
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production ...
STONY BROOK, NY / / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions ...
Origin-recognition complex, or ORC, plays an unexpectedly broad role in the regulation of human cell gene expression, according to ...
But a novel technique is allowing us to peer back further than DNA's expiration date in Africa, to answer long-standing ...
At two gene loci the researchers studied, increased looping in the absence of ORC2 isolated a known gene enhancer from the ...
Shifting from its pandemic response origins, the market is diversifying into new vaccines and oncology. Asset-light biotechs fuel this growth, making ...
A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.
RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against infection ...
It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...
Scientists once dismissed the theory that traits acquired during life could be inherited, but with new evidence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results